Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Klinicka Mikrobiologie a Infekcni Lekarstvi|December 22, 2022
[Can a difficult-to-treat resistance approach improve cooperation between microbiologists and clinicians?]Gabriela Kroneislová, Jan Závora, Váslava AdámkováKlinicka Mikrobiologie a Infekcni Lekarstvi|August 1, 2026
[Clostridioides difficile infection: Current perspectives on diagnosis and therapy]Gabriela Kroneislová, Jan Závora, Václava AdámkováAntibiotics (Basel, Switzerland)|November 27, 2024
Fosfomycin-Overcoming Problematic In Vitro Susceptibility Testing and Tricky Result Interpretation: Comparison of Three Fosfomycin Susceptibility Testing MethodsJan Závora, Gabriela Kroneislová, Marie Kroneisl, et al.Antibiotics (Basel, Switzerland)|August 28, 2025
In Vitro Activity of Cefiderocol and Aztreonam/Avibactam Against Gram-Negative Non-Fermenting Bacteria: A New Strategy Against Highly Antibiotic-Resistant Infectious AgentsJan Závora, Václava Adámková, Alžběta Studená, et al.Pathogens (Basel, Switzerland)|January 28, 2026
The Role of Routine Surveillance Cultures in Optimising Sepsis Management in High-Risk Patient GroupsJan Závora, Václava Adámková, Alžběta Studená, et al.Folia Microbiologica|January 26, 2024
Antimicrobial activity and properties of de novo design of short synthetic lipopeptidesGabriela Kroneislová, Anna Macůrková, Zuzana Novotná, et al.Microorganisms|November 25, 2023
Plant Growth-Promoting Endophytic Bacteria Isolated from Miscanthus giganteus and Their Antifungal ActivityPetra Lovecká, Gabriela Kroneislová, Zuzana Novotná, et al.Scientific Reports|April 9, 2024
In vitro activity of antibiotics potentially effective against difficult-to-treat strains of Gram-negative rods: retrospective studyGabriela Kroneislová, Jan Závora, Vanda Gabriela Adámková, et al.ACS Omega|August 19, 2024
Nitrogen-Containing Flavonoids-Preparation and Biological ActivityMartina Hurtová, Daniela Brdová, Bára Křížkovská, et al.Pharmaceutics|May 27, 2023
Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing ImplicationsJan Miroslav Hartinger, Danica Michaličková, Eliška Dvořáčková, et al.Pageof 2